Amanta Healthcare Ltd vs Bharat Immunological Biological Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Amanta Healthcare Ltd is ₹ 133.9 as of 06 May 15:30 . The P/E Ratio of Amanta Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Amanta Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Amanta Healthcare Ltd for the Dec '25 is ₹ 75.16 crore as compare to the Sep '25 revenue of ₹ 70.96 crore. This represent the growth of 5.92% The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Amanta Healthcare Ltd for the Dec '25 is ₹ 16.04 crore as compare to the Sep '25 ebitda of ₹ 12.09 crore. This represent the growth of 32.67% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Amanta Healthcare Ltd changed from ₹ -0.36 crore to ₹ 4.63 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Amanta Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Amanta Healthcare Ltd

Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm 'Marck Parenterals (India)' on January 06, 1995.
The Company's name was changed to 'Marck Biosciences Limited' on November 2, 2005 and further to 'Amanta Healthcare Limited' w.e.f.
June 24, 2014. vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat. Amanta Healthcare Limited is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, packed in plastic container with Aseptic Blow-Fill-Seal (ABFS) and Injection Strech Blow Moulding (ISBM) technology.
The Company manufacture large volume parenterals (LVPs) and small volume parenterals (SVPs) in six therapeutic segments.

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

FAQs for the comparison of Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd

Which company has a larger market capitalization, Amanta Healthcare Ltd or Bharat Immunological & Biological Corporation Ltd?

Market cap of Amanta Healthcare Ltd is 519 Cr while Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr

What are the key factors driving the stock performance of Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd?

The stock performance of Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd?

As of May 6, 2026, the Amanta Healthcare Ltd stock price is INR ₹133.9. On the other hand, Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.3.

How do dividend payouts of Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd compare?

To compare the dividend payouts of Amanta Healthcare Ltd and Bharat Immunological & Biological Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.